396 related articles for article (PubMed ID: 18071312)
1. Combinatorial action of the HDAC inhibitor trichostatin A and etoposide induces caspase-mediated AIF-dependent apoptotic cell death in non-small cell lung carcinoma cells.
Hajji N; Wallenborg K; Vlachos P; Nyman U; Hermanson O; Joseph B
Oncogene; 2008 May; 27(22):3134-44. PubMed ID: 18071312
[TBL] [Abstract][Full Text] [Related]
2. Defects in apoptotic signal transduction in cisplatin-resistant non-small cell lung cancer cells.
Ikuta K; Takemura K; Kihara M; Naito S; Lee E; Shimizu E; Yamauchi A
Oncol Rep; 2005 Jun; 13(6):1229-34. PubMed ID: 15870947
[TBL] [Abstract][Full Text] [Related]
3. Induction of apoptosis by trichostatin A, a histone deacetylase inhibitor, is associated with inhibition of cyclooxygenase-2 activity in human non-small cell lung cancer cells.
Choi YH
Int J Oncol; 2005 Aug; 27(2):473-9. PubMed ID: 16010430
[TBL] [Abstract][Full Text] [Related]
4. Endogenously released Smac is insufficient to mediate cell death of human lung carcinoma in response to etoposide.
Bartling B; Lewensohn R; Zhivotovsky B
Exp Cell Res; 2004 Aug; 298(1):83-95. PubMed ID: 15242764
[TBL] [Abstract][Full Text] [Related]
5. Preclinical evidence for a beneficial impact of valproate on the response of small cell lung cancer to first-line chemotherapy.
Hubaux R; Vandermeers F; Crisanti MC; Kapoor V; Burny A; Mascaux C; Albelda SM; Willems L
Eur J Cancer; 2010 Jun; 46(9):1724-34. PubMed ID: 20451370
[TBL] [Abstract][Full Text] [Related]
6. Predominant suppression of apoptosome by inhibitor of apoptosis protein in non-small cell lung cancer H460 cells: therapeutic effect of a novel polyarginine-conjugated Smac peptide.
Yang L; Mashima T; Sato S; Mochizuki M; Sakamoto H; Yamori T; Oh-Hara T; Tsuruo T
Cancer Res; 2003 Feb; 63(4):831-7. PubMed ID: 12591734
[TBL] [Abstract][Full Text] [Related]
7. Apoptosis-inducing factor determines the chemoresistance of non-small-cell lung carcinomas.
Gallego MA; Joseph B; Hemström TH; Tamiji S; Mortier L; Kroemer G; Formstecher P; Zhivotovsky B; Marchetti P
Oncogene; 2004 Aug; 23(37):6282-91. PubMed ID: 15286713
[TBL] [Abstract][Full Text] [Related]
8. Histone deacetylase inhibitor enhances sensitivity of non-small-cell lung cancer cells to 5-FU/S-1 via down-regulation of thymidylate synthase expression and up-regulation of p21(waf1/cip1) expression.
Noro R; Miyanaga A; Minegishi Y; Okano T; Seike M; Soeno C; Kataoka K; Matsuda K; Yoshimura A; Gemma A
Cancer Sci; 2010 Jun; 101(6):1424-30. PubMed ID: 20384633
[TBL] [Abstract][Full Text] [Related]
9. Vacuolar H+-ATPase inhibitors overcome Bcl-xL-mediated chemoresistance through restoration of a caspase-independent apoptotic pathway.
Sasazawa Y; Futamura Y; Tashiro E; Imoto M
Cancer Sci; 2009 Aug; 100(8):1460-7. PubMed ID: 19459857
[TBL] [Abstract][Full Text] [Related]
10. Thiosulfinates from Allium tuberosum L. induce apoptosis via caspase-dependent and -independent pathways in PC-3 human prostate cancer cells.
Kim SY; Park KW; Kim JY; Jeong IY; Byun MW; Park JE; Yee ST; Kim KH; Rhim JS; Yamada K; Seo KI
Bioorg Med Chem Lett; 2008 Jan; 18(1):199-204. PubMed ID: 18024112
[TBL] [Abstract][Full Text] [Related]
11. Isoobtusilactone A induces both caspase-dependent and -independent apoptosis in Hep G2 cells.
Liu TZ; Cheng JT; Yiin SJ; Chen CY; Chen CH; Wu MJ; Chern CL
Food Chem Toxicol; 2008 Jan; 46(1):321-7. PubMed ID: 17897765
[TBL] [Abstract][Full Text] [Related]
12. Late activation of apoptotic pathways plays a negligible role in mediating the cytotoxic effects of discodermolide and epothilone B in non-small cell lung cancer cells.
Bröker LE; Huisman C; Ferreira CG; Rodriguez JA; Kruyt FA; Giaccone G
Cancer Res; 2002 Jul; 62(14):4081-8. PubMed ID: 12124345
[TBL] [Abstract][Full Text] [Related]
13. Histone deacetylase inhibitor trichostatin A induced caspase-independent apoptosis in human gastric cancer cell.
Wu ZQ; Zhang R; Chao C; Zhang JF; Zhang YQ
Chin Med J (Engl); 2007 Dec; 120(23):2112-8. PubMed ID: 18167185
[TBL] [Abstract][Full Text] [Related]
14. Effects of trichostatin A, a histone deacetylase inhibitor, on the regulation of apoptosis in H-ras-transformed breast epithelial cells.
Park H; Lee YJ; Kim TH; Lee J; Yoon S; Choi WS; Myung CS; Kim HS
Int J Mol Med; 2008 Nov; 22(5):605-11. PubMed ID: 18949380
[TBL] [Abstract][Full Text] [Related]
15. Role of mitochondria in quercetin-enhanced chemotherapeutic response in human non-small cell lung carcinoma H-520 cells.
Kuhar M; Sen S; Singh N
Anticancer Res; 2006; 26(2A):1297-303. PubMed ID: 16619537
[TBL] [Abstract][Full Text] [Related]
16. Effect of histone deacetylase inhibitors trichostatin A and valproic acid on etoposide-induced apoptosis in leukemia cells.
Jasek E; Lis GJ; Jasinska M; Jurkowska H; Litwin JA
Anticancer Res; 2012 Jul; 32(7):2791-9. PubMed ID: 22753739
[TBL] [Abstract][Full Text] [Related]
17. The histone deacetylase inhibitor trichostatin A induces cell cycle arrest and apoptosis in colorectal cancer cells via p53-dependent and -independent pathways.
Meng J; Zhang HH; Zhou CX; Li C; Zhang F; Mei QB
Oncol Rep; 2012 Jul; 28(1):384-8. PubMed ID: 22552631
[TBL] [Abstract][Full Text] [Related]
18. Denbinobin induces apoptosis in human lung adenocarcinoma cells via Akt inactivation, Bad activation, and mitochondrial dysfunction.
Kuo CT; Hsu MJ; Chen BC; Chen CC; Teng CM; Pan SL; Lin CH
Toxicol Lett; 2008 Feb; 177(1):48-58. PubMed ID: 18262737
[TBL] [Abstract][Full Text] [Related]
19. Induction of apoptosis by combined treatment with differentiation-inducing agents and interferon-alpha in human lung cancer cells.
Yamamoto-Yamaguchi Y; Okabe-Kado J; Kasukabe T; Honma Y
Anticancer Res; 2003; 23(3B):2537-47. PubMed ID: 12894538
[TBL] [Abstract][Full Text] [Related]
20. Nuclear factor-kappaB inhibition by parthenolide potentiates the efficacy of Taxol in non-small cell lung cancer in vitro and in vivo.
Zhang D; Qiu L; Jin X; Guo Z; Guo C
Mol Cancer Res; 2009 Jul; 7(7):1139-49. PubMed ID: 19584264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
